Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision

Journal of Surgical Oncology

Volumn 83, Issue 3, 2003, Pages 133-139

  Colquhoun, Patrick ^a   Wexner, Steven D ^a   Cohen, Alfred ^b  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMORADIOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COLON RESECTION; CONTROLLED CLINICAL TRIAL; DIARRHEA; EDITORIAL; FOLLOW UP; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; NAUSEA; OUTCOMES RESEARCH; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RECTUM SURGERY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; SURGICAL TRAINING; TOTAL MESORECTAL EXCISION;

CLINICAL TRIALS; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; RECTUM;

EID: 0038016867     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10267     Document Type: Editorial

References (49)

1. American Cancer Society, Inc. Cancer facts and figures. New York: American Cancer Society, Inc. 2002.
2. Cheng C, Rodriguez-Bigas M, Miguel A, et al.: Is there a role for curative surgery for pelvic recurrence from recta carcinoma in the presence of hydronephrosis? Br J Surg 2001;182:274-277.
3. Yamada K, Ishizawa T, Niwa K, et al.: Patterns of pelvic invasion are prognostic in the treatment of recurrent rectal cancer. Br J Surg 2001;88:988-993.
4. Camilleri-Brennan J, Steele RJC: The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001;27:349-353.
5. Miller AR, Cantor SB, Peoples GE, et al.: Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum 2000;43:1695-1703.
6. Bozzetti F, Bertario L, Rossetti C, et al.: Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 1997;40:1421-1424.
7. Wanebo HJ, Koness RJ, Turk PS, et al.: Composite resection of posterior pelvic malignancy. Ann Surg 1992;215:685-695.
8. Wanebo HJ, Antoniuk P, Koness J, et al.: Pelvic resection of recurrent rectal cancer. Dis Colon Recum 1999;42:1438-1448.
9. Mannaerts GHH, Rutten HJT, Martijn H, et al.: Abdominosacral resection for primary irresctable and locally recurrent rectal cancer. Dis Colon Rectum 2001;44:806-814.
10. Stockholm Rectal Cancer Study Group: Preoperative short-term radiation therapy in operable rectal carcinoma. Cancer 1990;66:49-55.
11. Gastrointestinal Tumour Study Group: Prolongation of the disease free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-1472.
12. Krook JE, Moertel CG, Gunderson LL, et al.: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;14;324:709-715.
13. Fisher B, Wolmark N, Rockette H, et al.: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21-29.
14. Wolmark N, Wieand HS, Hyams DM, et al.: Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2001;92:388-396.
15. Norwegian Adjuvant Rectal Cancer Project Group: Randomized controlled trial of postoperative radiotherapy and short-term time scheduled 5 fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997;84:1130-1135.
16. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-987.
17. Gerard A, Buyse M, Nordlinger B, et al.: Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988;208:606-614.
18. Pahlman L, Glimelius B: Pre or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Ann Surg 1990;211:187-195.
19. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
20. Heald RJ, Ryall RD: Recurrence and survival after total mesorecta excision for rectal cancer. Lancet 1986;28:1479-1482.
21. Heald RJ, Moran BJ, Ryall R, et al.: Rectal cancer. Arch Surg 1998;133:894-899.
22. McFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993;341:457-460.
23. Leong AFPK: Selective total mesorectal excision for rectal cancer. Dis Colon Rectum 2000;43:1237-1240.
24. Merchant NB, Guillem JG, Paty PB, et al.: T3N0 rectal cancer: Results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 1999;3:642-647.
25. Martling AL, Holm T, Rutqvist LE, et al.: Effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm. Lancet 2000;356:93-96.
26. Tocchi A, Mazzoni G, Lepre L, et al.: Total mesorectal excision and low rectal anastomosis of rectal cancer and prevention of pelvic recurrences. Arch Surg 2001;136:216-220.
27. Leo E, Belli F, Andreola S, et al.: Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: The experience of the National Cancer Institute of Milano. Ann Surg Oncol 2000;7:125-132.
28. Hartley JE, Mehigan BJ, Qureshi AE, et al.: Total mesorectal excision: Assessment of the laparoscopic approach. Dis Colon Rectum 2001;44:315-321.
29. Zaheer S, Pemberton JH, Farouk R, et al.: Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998;227:800-811.
30. Kerman HD, Roberson SH, Bloom TS, et al.: Rectal carcinoma. Long-term experience with moderately high-dose preoperative radiation and low anterior resection. Cancer 1992;69:2813-2819.
31. Wiggers T, Van de Velde CJH: The circumferential margin in rectal cancer: Recommendations based on the Dutch total mesorectal excision study. Eur J Cancer 2002;38:973-976.
32. Hu K, Harrison LB: Adjuvant therapy for resectable rectal adenocarcinoma. Semin Surg Oncol 2000;19:336-349.
33. Quirke P, Durdey P, Dixon MF, et al.: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996-999.
34. Reynolds JV, Joyce WP, Dolan J, et al.: Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996;83:1112-1115.
35. Hall NR, Finan PJ, Al-Jaberi T, et al.: Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Dis Colon Rectum 1998;41:979-983.
36. Wibe A, Rendedal PR, Svensson E, et al.: Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327-334.
37. Bribeck KF, Macklin CP, Tiffin NJ, et al.: Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449-457.
38. Scott N, Jackson P, Al-Jaberi T, et al.: Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 1995;82:1031-1033.
39. Hida JI, Yasutomi M, Maruyama T, et al.: Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing methods: Justification of total mesorectal excision. J Am Coll Surg 1997;187:584-848.
40. Solomon MJ, Egan M, Roberts RA, et al.: Incidence of free colorectal cancer cells on the peritoneal surface. Dis Colon Rectum 1997;40:1294-1298.
41. IH Consensus Development Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450.
42. Nagawa H, Muto T, Sunouchi K, et al.: Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001;44:1274-1280.
43. Porter GA, Soskolne CL, Yakimets WW, et al.: Surgeon related factors and outcomes in rectal cancer. Ann Surg 1998;227:157-167.
44. Schoetz DJ: Colon and rectal surgery. A true subspecialty. Dis Colon Rectum 1998;41:1-10.
45. Ritchie WP, Rhodes RS, Biester TW: Work loads and practice patterns of general surgeons in the United States, 1995-1997. A report from the American Board of Surgery. Ann Surg 1999;230:533-543.
46. Harmon JW, Tang DG, Gordon TA, et al.: Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg 1999;230:404-413.
47. Ooi BS, Tjandra JJ, Green MD: Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer. Dis Colon Rectum 1999;42:403-418.
48. Dahl O, Horn A, Morild I: Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer 1990;66:2286-2294.
49. Medical Research Council Rectal Cancer Working Party: Randomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996;348:1610-1614.